Total Number of Communication Reports: 100
Monthly communication reports in the last 6 months: 0
PHARMACEUTICAL COMPANY Manufacturing and distribution of Generic Prescription Pharmaceuticals Products
Douglas Sommerville, Senior Vice President and General Manager
Address:
30 Novopharm Court
Toronto, ON M1B 2K9
Canada
Telephone number:
416-940-6767
Teva Canada Limited / Teva Canada Limitee does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
Teva Canada Limited/Teva Canada Limitee | 2024-07-18 | current |
Teva Canada Limited/Teva Canada Limitee | 2010-11-15 | 2024-07-18 |
Teva Novopharm | 2009-01-13 | 2009-09-03 |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|---|---|
Fabien Paquette | 2024-07-29 | Current |
Michael Sine | 2022-07-26 | 2024-07-29 |
Christine Poulin | 2018-04-01 | 2022-07-26 |
Douglas Sommerville | 2014-01-01 | 2018-04-01 |
Barry Fishman | 2009-01-13 | 2014-01-01 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.